Physician profile

William D Gilbert

General Practice (Dentist) · Granite Bay, CA

NPI 1265456651

$2,656.75

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$95.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Patterson Companies, INC. $1,849.00 2019-2021
Scican INC $536.00 2020
A-Dec, INC. $92.00 2021
3m Company $80.19 2022-2023 3m Filtek, Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative
Dentsply Sirona INC $32.11 2019
Straumann USA LLC $25.48 2024
Ormco Corporation $14.04 2023 Spark
Nobel Biocare USA $14.04 2023 Nobelactive
Dentsply Ih INC. $13.89 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

William D Gilbert

$2,656.75

in general payments reported 2019-2025

Years
2019-2024
Top company
Patterson Companies, INC.

https://glasscript.com/doctor/147633/william-d-gilbert

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.